Skip to main content
FERMENTA BIOTECH LIMITED logo

FERMENTA BIOTECH LIMITED — Investor Relations & Filings

Ticker · FERMENTA ISIN · INE225B01021 LEI · 335800VNTNWW8G1U9314 BSE.NS Manufacturing
Filings indexed 663 across all filing types
Latest filing 2026-05-19 Regulatory Filings
Country IN India
Listing BSE.NS FERMENTA

About FERMENTA BIOTECH LIMITED

https://fermentabiotech.com

Fermenta Biotech Limited is a specialized biotechnology company primarily focused on the development and manufacture of Vitamin D3 (Cholecalciferol). As one of the few vertically integrated manufacturers globally, the company produces Vitamin D3 for diverse applications, including pharmaceuticals, dietary supplements, human nutrition, and animal feed. Beyond its core Vitamin D3 portfolio, the company offers a range of specialty enzymes, particularly for the synthesis of beta-lactam antibiotics, and provides environmental solutions through its biotechnology expertise. Fermenta Biotech emphasizes high-quality standards, maintaining various international certifications for its manufacturing facilities. Its product offerings extend to premixes and value-added formats designed to meet specific formulation requirements. The company serves a global clientele, leveraging its research and development capabilities to innovate in the fields of nutrition and biotechnology.

Recent filings

Filing Released Lang Actions
Fermenta Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/05/2026 ,inter alia, to consider and approve audited financial results ....
Regulatory Filings Classification · 91% confidence The document is a notice to the stock exchange (BSE) under SEBI Listing Regulations informing the date and agenda of an upcoming Board of Directors meeting (to approve audited results and consider dividend). It does not contain any financial statements or substantive data itself (so it’s not an IR or 10-K), nor is it an actual report or presentation. It also is not a change of board personnel (so not MANG), nor is it a proxy or voting result. It is a regulatory announcement of a board meeting under listing rules, which falls under the general “Regulatory Filings” category.
2026-05-19 English
Publication of IEPF related notice for equity shareholders
Report Publication Announcement Classification · 85% confidence The document is a letter from the Company Secretary to the BSE pursuant to SEBI LODR Regulation 47 enclosing a photocopy of a newspaper publication (“Notice to equity shareholders”) dated May 7, 2026. It does not contain substantive financial data or voting results, nor is it the notice itself, but rather an announcement that the notice has been published in newspapers and is enclosed for record. This fits the definition of a Report Publication Announcement (RPA).
2026-05-07 English
Newspaper Publication for Notice for Special window for Transfer and Dematerialisation of Physical Securities.
Regulatory Filings
2026-04-28 English
Format of the Annual Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars ....
Regulatory Filings
2026-04-28 English
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details ....
Regulatory Filings
2026-04-28 English
The Company''s shares have been admitted by NSE under ''Permitted to trade'' category on National Stock Exchange (Capital Market Segment).
Regulatory Filings
2026-04-21 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.